Kriya Therapeutics, Inc. ("Kriya"), a biotechnology company developing durable medicines for chronic diseases, today announced it has been selected by the U.S. Food and Drug Administration (FDA) to ...
Erik Steiger discusses the operational pain of legacy PDF generation in regulated banking and manufacturing. He explains how ...
LBMX, the world's leading buying group platform, today announced the addition of two accomplished leaders to its executive ...